| PACKAGING TYPE: | 10x1x10 (10 Strips In 1 Box) |
| COMPOSITION: | Obeticholic Acid Tablets 10mg |
| FORMULATION: | Tablets |
| Description: | OBETISAFE-10 Tablet contains Obeticholic Acid 10 mg, a bile acid analogue used in the treatment of Primary Biliary Cholangitis (PBC), a chronic liver disease that damages the bile ducts. It is commonly prescribed for patients who do not respond adequately to Ursodeoxycholic Acid or who cannot tolerate it. Obeticholic Acid works by activating the Farnesoid X Receptor (FXR), which helps regulate bile acid production and reduce inflammation in the liver. This mechanism improves bile flow and slows the progression of liver damage, helping maintain better liver function in patients with PBC. |
| Side Effects: | Some individuals may experience mild side effects such as: Itching (pruritus) Fatigue Abdominal pain Joint pain Constipation Seek medical attention if symptoms worsen or if severe allergic reactions occur. |
| How to Use: | Take OBETISAFE-10 Tablet exactly as prescribed by a healthcare professional. Swallow the tablet with water, with or without food. Take the medication at the same time each day for consistent results. Do not stop taking the medicine without consulting your doctor. |
| Precaution: | Use only under strict medical supervision. Inform your doctor if you have advanced liver disease or liver cirrhosis. Regular liver function tests may be required during treatment. Pregnant or breastfeeding women should consult a healthcare professional before use. Avoid alcohol or hepatotoxic substances unless advised by your doctor. Store in a cool and dry place away from direct sunlight. Keep out of reach of children. |
| Product Benefits: | Helps manage primary biliary cholangitis. Improves bile flow and liver function. Reduces liver inflammation and bile acid accumulation. Helps slow progression of chronic liver disease. Suitable for patients who do not respond to ursodeoxycholic acid t |
Frequently Asked Questions
OBETISAFE-10 Tablet is used for the treatment of primary biliary cholangitis, a chronic liver disease affecting the bile ducts.
It activates the Farnesoid X receptor (FXR), which helps regulate bile acid production and reduce liver inflammation.
Yes, it is often prescribed in combination with Ursodeoxycholic Acid when the response to that therapy alone is insufficient.










